You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 167 No. 8, April 23, 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in this journal
 Topic Collections
 •Diabetes Mellitus
 •Hypertension
 •Nutritional and Metabolic Disorders, Other
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic

COMMENTS & OPINIONS
Exogenous Insulin Use and Hypertension

Jaewon Oh, MD; Ji Hyung Chung, PhD; Yangsoo Jang, MD, PhD

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The meta-analysis of the exogenous insulin use and hypertension in type 2 diabetes mellitus by Tseng1 showed that insulin users were at higher risk for development of hypertension compared with nonusers, suggesting there might be an unknown relationship between exogenous insulin use and hypertension. Hyperinsulinemia, along with insulin resistance, is a well-known risk factor for hypertension, but whether insulin itself could have the potential for the development of hypertension independent of insulin resistance is controversial. Therefore, the underlying mechanisms of insulin-induced hypertension remain to be studied further, although there are some explanations suggested by Tseng1 such as induction of oxidative stress and increased plasma catecholamine levels.

A recent basic research study might provide a novel explanation for this phenomenon. Visfatin, an adipokine, has been reported to lower plasma glucose levels through binding and activating the insulin receptor.2 Haider et . . . [Full Text of this Article]


AUTHOR INFORMATION

RELATED LETTERS

High Recurrence Rate of CA-MRSA Skin and Soft Tissue Infections
Daniel J. Skiest and Travis W. Cooper
Arch Intern Med. 2007;167(22):2527.
EXTRACT | FULL TEXT  

High Recurrence Rate of CA-MRSA Skin and Soft Tissue Infections—Reply
Lalita Shastry and Joseph Rahimian
Arch Intern Med. 2007;167(22):2527.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.